Final answer:
The second controversy around GID or Gender Dysphoria revolves around its diagnostic name and implications, which was changed from 'Gender Identity Disorder' to 'Gender Dysphoria' in the DSM-5 to reduce stigma and better facilitate healthcare and legal recognition for transgender individuals.
Step-by-step explanation:
The second controversy regarding gender identity disorder (GID) or Gender Dysphoria pertains to changes in its diagnostic categorization. In earlier versions of the DSM, notably the DSM-IV, the term 'Gender Identity Disorder' was used, which many gender-variant individuals found offensive due to the implication of being 'disordered.' With the introduction of the DSM-5, the term was changed to 'Gender Dysphoria' to reduce stigma while still allowing individuals to access needed treatment, such as hormone therapy and gender reassignment surgery. This change also aligns with the movements in health care and legal systems to recognize and address the needs and rights of transgender individuals more responsively.
For instance, the U.S. Department of Education ruled that schools receiving federal funds may not discriminate against transgender students. Furthermore, decisions by the Department of Health and Human Services extended Medicare coverage to include sexual reassignment surgery, influencing private insurance coverage decisions. These strides reflect a growing awareness and acknowledgement of transgender rights and the necessity for appropriate care.